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Abstract 
 
Purpose: Oxygen uptake kinetics (VO2) is a key determinant of endurance performance. 
Ischemic preconditioning (IPC) has been shown to potentially enhance endurance 
performance. The aim of the present study was to investigate the effects of ischemic 
preconditioning on VO2 and muscle oxygenation kinetics during sub-maximal cycling 
exercise and to compare with hypoxic (HPC) or hypoxic-ischemic (HIPC) preconditioning. 
Methods: In a single-blind, crossover randomized study, fourteen active men and women 
(age [mean ± SD standard deviation]) = 25.4 ± 2 years, body mass = 71.8 ± 10.7 kg, body 
height = 179.6 ± 11.2 cm) performed 3 x 6 minutes sub-maximal cycling exercise, with 6 
minutes recovery. Those sub-maximal bouts were performed after 40 min recovery after a 
preconditioning phase of 4 x 5 min periods of cycling at 1.5 W/kg at 85 rpm either with 
bilateral leg occlusion at 30 mmHg in normoxia (Control/CON) in normobaric hypoxia (HPC, 
FIO2 13.6%) at 60% of relative total occlusion pressure in normoxia (IPC), or in hypoxia and 
60% of the total occlusion pressure (HIPC, FIO2 13.6%) with 5-min periods of rest.  
Results: None of the three PC conditions induced a beneficial change in the VO2 or muscle 
oxygenation kinetics. Further, HPC altered the VO2 kinetics, while slowing the time constant 
of the VO2 kinetics. When added to ischemia (HIPC), hypoxia blunted the effect of the 
ischemia on the muscle oxygenation. IPC, HPC and HIPC had no influence on the respiratory 
efficiency or the work efficiency. Further, IPC has a hyperemic effect on the sub-maximal 
performance and seemed to induce a greater muscle perfusion. 
Conclusion: This study investigated four preconditioning conditions (control, IPC, HPC and 
HIPC), in which HPC slows the VO2 kinetics and IPC has a hyperemic effect on the sub-
maximal performance. No other parameters have a potentially ergogenic effect on the sub-
maximal performance. 
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Δ : Delta 
[O2Hb]: Oxyhemoglobin concentration 
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PC: Preconditioning VO2	: Pulmonary oxygen uptake VO2	max: Maximal oxygen uptake  VO2	peak	: Peak oxygen uptake 
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HPC: Hypoxic preconditioning 
HIPC: Hypoxic-ischemic preconditioning 
Tocc: Total occlusion pressure (mmHg) 
O2 : Oxygen  
PaO2 : Arterial oxygen pressure  
CT1: Time constant (seconds) of the kinetics 
TD1: Time delay (seconds) of the kinetics 
GE: Gross efficiency (%) 
EE: Energy expenditure (J/S) 
RER: Respiratory exchange ratio 
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1. Introduction   	
Traditionally, athletes have achieved peak performance goals through long-term structured 
training schedules. Investigations have observed a variety of methods for optimizing training 
protocols from increasing strength to improving aerobic endurance (Jones, 2004). However, 
other kind of training methods performed just before the competitions have been shown to 
improve the performance. On competition days, sports scientists and coaches exploit a variety 
of strategies to improve athletes’ performances, such as warm-up exercises, supplementation 
with stimulants, passive heat maintenance, and post-activation potentiation (Carr Aj, 2011) 
(Smith Mike, 2004) (Kilduff Liam P, 2013). The influence of the warm-up on subsequent 
aerobic exercise performance has been investigated since 1930 (Simonson E, 1936). The 
warm-up has been associated with acute increases in peripheral and central circulation and 
elevated core and muscle temperature (Simonson E, 1936). A study found that performance in 
both aerobic and anaerobic criterion tasks was significantly improved when preceded by 
warm-up of 15-minute intermittent treadmill at 60% of maximal oxygen consumption, 
compared with no warm-up (Simonson E, 1936).  This result demonstrates the importance of 
the warm-up methods to enhance performance.  
Scientists are using a new, non-invasive method “preconditioning” to further understand 
potential benefits of warm-ups. The American Heart Association defines this method as a 
“process where the exposition of an organism, an organ or a cell to a moderate stress, protect 
him or her in the next day from a bigger stress ”. There are two methods of creating the 
preconditioning stimulus condition, the ischemic preconditioning (IPC) and the hypoxic 
preconditioning (HPC).  
 
Originally introduced by Murry Charles E (1986), “ IPC by brief episodes of ischemia and 
reperfusion in the organs, especially the heart provides protection from tissue damage such as 
myocardial injury”. Sharma and colleagues stated that “IPC is a phenomenon in which 
transient episodes of ischemia and reperfusion administered to an organ attenuate the lethal 
cellular injury sustained from a subsequent, prolonged ischemic insult of the same organ” 
(Sharma Vikram , 2015). Since 1986, IPC has been demonstrated to protect many organs, 
including the myocardium (Cho Y Pang, 1995), the liver (Murry Charles E, 1986) and 
skeletal muscle (De Groot Patricia, 2010) from the damage caused by a subsequent prolonged 
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ischemic event. Research has shown that IPC can also decrease the chance of myocardial 
infarction and protect the endothelium (Alves Lintz José, 2013). In the recent years, IPC has 
been shown to enhance performance during endurance exercise (Przyklenk K, 1993) however 
the mechanisms underlying these improvements are still unclear. 
Exercise performance is determined by many factors however; oxidative metabolism may be 
considered the most important (Patterson S D, 2014.). The dynamics of pulmonary oxygen 
uptake (VO2) and muscle deoxygenation during exercise are frequently used for assessing 
oxygen (O2) supply and extraction (Patterson S D, 2014.). These systemic and local O2 
dynamics may be useful for understanding the beneficial effects of IPC on exercise 
performance (Kido Kohei, 2015). IPC is believed to release circulating protective factors into 
the bloodstream during repeated cycles of inflation and deflation of a standard blood pressure 
cuff on a limb, producing significant benefits with respects to hypoxic-ischemic tissue injury 
(Liu Jing, 2005). Across a range of various exercise modes, performance has been enhanced 
by 1-8 % (Przyklenk K, 1993) (Liu Jing, 2005) (De Groot Patricia, 2010) (Kjeld Thomas, 
2014) (Bailey Stephen J, 2010) which makes it potentially beneficial for athletic events which 
small margins are the difference between winning or losing. Research to date has primarily 
focused on events of an endurance nature and has identified improvements in maximal 
oxygen uptake (VO2max) (Bailey Stephen J, 2010), power output at VO2max (Jean-St-Michel E, 
2011), running time trial performance (De Groot Patricia, 2010), and 1000m rowing 
performance (Kido Kohei, 2015). Relatively little research has focused on performance 
during shorter durations. Some studies have found that IPC accelerated muscle deoxygenation 
kinetics in a moderate intensity cycling exercise (Liu Jing, 2005) and increased peak oxygen 
uptake (VO2peak ) during a maximal ramp exercise test (Bailey TG, 2012). The VO2peak is 
strongly affected by the cardiovascular system in addition to peripheral systems, which 
suggests that IPC induced improvements in exercise performance may result from peripheral 
adaptations, including those in the skeletal muscle rather than cardiovascular adaptation 
(Sharp Frank, 2004). Contrarily, researchers have also shown that IPC could increase 
endurance performance without affecting VO2 responses (Gürke L, 1996). IPC has resulted in 
improved metabolic efficiency by attenuating ATP depletion (Enko K, 2011), glycogen 
depletion (Phillips D J, 1997), and lactate production (Enko K, 2011) during prolonged 
ischemia. In addition, IPC may improve skeletal muscle blood flow by inducing conduit 
artery vasodilatation (Crewe H, 2008), enhancing functional sympatholysis (Crewe H, 2008), 
and preserving endothelial and microvascular function during stress. In another study, an 
	 9	
increase in neural drive to the actives muscles has also been speculated, as the surface 
electromyography (EMG) potentials and maximal isometric force were increased in skeletal 
muscle of animals following IPC (Åstrand Per-Olof, 1964), suggesting increased motor unit 
recruitment. Unfortunately, the effect of IPC on EMG amplitude has not yet been investigated 
in exercising humans. It has also been suggested that IPC lowers the sensitivity of the body to 
fatigue signals. This should result in lower ratings of conscious perception of effort (RPE) 
during a constant load exercise, as it is derived from sensory input arriving from many 
different biological systems, including the cardiovascular, respiratory, and musculoskeletal 
systems (Åstrand Per-Olof, 1964). IPC can also ameliorate the O2 response during ischemia 
potentially by increasing nitric oxide (NO) production. An increase of NO levels has 
enhanced exercise endurance and had modified systemic and local O2 responses during 
exercise (Larsen Filip J, 2001). One potential mechanism underlying IPC induced effects may 
be the acceleration of systemic and local O2 dynamics due to NO – dependent mechanisms 
(Larsen Filip J, 2001). 
The second type of preconditioning stimulus is hypoxic preconditioning (HPC). Hypoxia is 
defined as a decrease in tissue or ambient tissue oxygen concentration below normal (Sharp 
Frank R, 2004). HPC has been studied in the brain, heart, retina, and other tissues (Sharp 
Frank R, 2004). The initial preconditioning stimulus is believed to trigger a cascade of 
endogenous adaptive mechanisms resulting in the development of tolerance (Englander EW, 
1999). Depending on the nature of the preconditioning stimulus, delayed tolerance is initiated 
for several hours and can persist for several days (Bergerson, 2001). HPC has been shown to 
protect the brain and the heart against ischemia, as well as protect the brain from several types 
of injury including ischemia seizures and edema (Emerson MR, 1999). HPC protects many 
types of ischemia including focal and global ischemia in adult and neonatal brain with and 
without reperfusion (Sasaki H, 2001). Many of the molecules implicated in various other 
types of preconditioning are also induced by hypoxia or hypoxia induced tolerance (Sasaki H, 
2001). These molecules induced by hypoxia are known to be protective similar to 
erythropoietin (EPO) or vascular endothelial growth factor (VEGF). In addition, ischemia, 
thrombin, hemorrhage, and possibly hypoglycemia all induce hypoxia inducible factor (HIF) 
and HIF target genes (Englander EW, 1999).  Little is known about the mechanisms that 
occur in the time period between hypoxic preconditioning and the development of tolerance 
to brain ischemia. Hypoxic tissue induces a broad range of adaptive responses including 
electrophysiological and biochemical modification (Haddad GG, 1997 ). In addition, hypoxia 
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stimulates the expression of many genes, some of which are involved in erythropoiesis, 
angiogenesis, vasodilatation, glucose transport, and stimulation of anaerobic glycolysis 
(Simon, 1999). Finally, mild to moderate hypoxia (> 8% oxygen) does not produce cell death 
in the brain if hypoxia does not produce cardiac arrhythmias and hypotension (Simon, 1999). 
However, recent studies show that hypoxia can damage both nuclear and mitochondrial DNA 
in brain cells and that this stimulates DNA repair (Englander EW, 1999). Therefore, the 
studies inducing hypoxia have to be controlled very carefully.  
 
In a human live, there are many different metabolic rates required to perform various tasks, 
for example, get up from a chair, climb stairs, run to catch a bus, or engage in activities 
requiring physical labor or professional sports. Due to very limited non-oxidative muscle 
energy stores, at the transition from rest to exercise, there must be simultaneous pulmonary, 
cardiovascular, and muscular system responses that rapidly increase the flux of O2 from the 
atmosphere to the muscles, specifically to the mitochondria allowing for ATP production 
(Grassi B, 2011). These transitory phases, prior to achievement of any steady state responses 
suggests that a finite metabolic capacitance may have evolved as a crucial feature of the 
energy transfer pathways. At present, the kinetic response of VO2 following the onset of 
exercise is recognized as a sentinel parameter of aerobic function and its measurement is 
becoming standard in laboratories around the World (Poole David C, 2012). In view of the 
relationship between physical performance and VO2 kinetics, the development of strategies 
aimed at enhancing VO2 kinetics and reducing the size and/or the progression of the VO2 slow 
component offer hope for improving exercise tolerance (Gaesser, 1996). 
The VO2 kinetics can be split into three phases. The first phase is the cardiodynamic 
adaptation, in which the rapidity of the phase response is attributed to the almost 
instantaneous cardiac output increase as initiated by vagal withdrawal and the mechanical 
pumping action of the contracting muscles (Poole David C, 2012). The second phase is the 
main phase, where the rate of VO2 increase is quantified by the time constant (CT). The time 
constant of the VO2 kinetics translates the capacity of an athlete to regulate the VO2 steady 
state, τ denoting the time to reach 63% of the primary phase. τVO2 is a fundamental 
parameter of aerobic performance and differences in τVO2 (speed of the VO2 kinetics) may 
help explain the broad range of physical capabilities and exercise tolerance across populations 
(Kido Kohei, 2015).  The faster this second phase can be achieved the better, in part, because 
this incurs a smaller O2 deficit for any given increase in VO2, and intracellular perturbations 
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are minimized (Grassi B, 2011). The third phase is the steady state / slow component phase. 
During a moderate intensity exercise, an athlete reaches steady state, however, with heavy or 
severs intensities, a slow component is observed. The slow component of O2 uptake kinetics 
in long term constant rate exercise can be described as an increase in the energy expenditure 
above that predicted from the sub-maximal VO2 work rate relationship, leading to a reduced 
work efficiency (Whipp BJ, 1970). 
An important parameter to mesure the perfromance is the efficiency. Indeed efficiency has 
been suggested to be an important factor in relation to obesity (Sidossis L.S, 1992), weight 
loss (Lammert O, 1982), exercise performance (Olds T, 1995) and hence it is important to 
know the reproducibility of this measurement. For example, cyclists with very similar 
physiology and using similar equipment may display large differences in exercise 
performance as a result of small differences in efficiency (Jeukendrup A.E, 2000). The gross 
efficiency (GE) is an important parameter of the total efficiency. The basic definition of gross 
efficiency (Sidossis L.S, 1992) is the ratio of work done during the specific activity to the 
total energy expended and expressed as a percentage. Gaesser and Brooks (Gaesser G.A, 
1975) suggested that GE distorts the essentially linear relationship between work rate and 
energy expenditure to make it appear that efficiency increases with work rate. This distortion 
occurs due to the proportion of energy expenditure that is used to maintain homeostasis 
becoming smaller as total energy expenditure increases.  
The respiratory exchange rate (RER) is also an important parameter to evaluate the efficiency 
of the work. The (RER) indirectly shows the muscle’s oxidative capacity to get energy 
(Ramos-Jiménez Arnulfo, 2008). The RER (CO2 production/O2 uptake) increase with the 
exercise intensity and measured under steady state conditions is commonly used to indirectly 
determine the relative contribution of carbohydrate and lipids to overall energy expenditure 
(Simonson DC, 1990). A high RER indicates that carbohydrates are being predominantly 
used, whereas a low RER suggests lipid oxidation (Simonson DC, 1990). Moseley and al 
(2001) founded that once the RER rose consistently above 1.00 for an entire workload, the 
measures of energy expenditure were no longer valid due to the contribution of unmeasured 
anaerobic work. 
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In this context, a recent study by Kido et al. (2015) examined the effects of IPC of the lower 
limb on the VO2 kinetics and muscle deoxygenation during square wave transitions from low 
to moderate intensity, as well as from moderate to severe intensity cycling exercise (Kido 
Kohei, 2015). They found that IPC increased the time to exhaustion, which supports an 
increase in exercise performance. Furthermore, this group concluded that IPC did not change 
the pulmonary VO2 kinetics but changed the kinetics of muscle deoxygenation. Specifically, 
IPC accelerated the kinetics in the transition from low to moderate intensity exercise (the 
amplitude of the deoxyhemoglobin (HHb) /Myoglobin (Mb) response was reduced), but no 
change of the kinetics was demonstrated in moderate to severe intensity exercise. Other 
studies have investigated the IPC effect on the balance between O2 utilization and delivery in 
the microcirculation via near-infrared spectroscopy (NIRS). Indeed, Barbosa et al (2015) 
found an improvement of exercise tolerance accompanied by higher HHB/ Mb at peak 
exercise compared to the control (Barbosa T.C, 2015). Furthermore, Patterson et al. (2014) 
reported greater tissue oxygenation in leg cycling when sprints were preceded by IPC 
(Patterson S D, 2014.). These two opposite results elude that the effect on IPC on muscle 
deoxygenation and on other mechanisms during exercise still needs clarification.  
 
It is known that different exercise intensities alter the VO2 kinetics. Moderate intensity is 
below the gas exchange threshold (GET), heavy intensity is above the GET but under the 
critical power (CP), severe intensity is above the CP, which leads to VO2max, and extreme 
intensity is such that fatigue ensures before VO2max is achieved (Poole David C, 2012). The 
response to the preconditioning depends also of the intensity (Kido Kohei, 2015).  
 
 
The purpose of the current study is to investigate the effect of the ischemic and hypoxic 
preconditioning on the VO2 and muscle oxygenation kinetics during a sub-maximal exercise. 
The intensity corresponds to a heavy exercise as described above. We have examined the 
physiological responses, VO2 and muscle oxygenation kinetics and tested three hypotheses: 
  
i. The ischemic and hypoxic preconditioning have a potentially ergogenic effect on the 
sub-maximal performance compared with the control condition. 
ii. The ischemic and/or hypoxic preconditioning will enhance the VO2 kinetics by 
enhancing the time constant.  
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iii. The combination of the ischemic and the hypoxic condition during the preconditioning 
has no supplementary effect on the sub-maximal performance than the hypoxic / 
ischemic preconditioning alone. 
2. Methods 
2.1 Participants 
In a randomized, single blind, crossover study, 14 healthy male and female subjects (age 
[mean ± SD (standard deviation)] = 25 ± 3 years, body mass = 71.8 ± 10.7 kg, height = 179.7 
± 11.8 cm) accepted to participate in the current study. All subjects approved being active 
(minimum two training sessions per week). None of the subjects were informed about the 
effect of ischemic or hypoxic preconditioning. All the subjects were able to complete the 
entire study, thus 14 subjects were taken for the data’s analysis. This study was approved by 
the ethics committee (Commission Cantonale d’Ethique de la Recherche sur l’être Humain 
number 138/15, approved on 21.04.2015). 
 
2.2 Experimental procedure 
Subjects (n=14) completed five visits in the hypoxic chamber of ISSUL (University of 
Lausanne Sport Science Institute) located at Dorigny in the sport center “CSS” (Centre Sport 
Santé). All visits were performed in a randomized order, at the same time of day, and 
separated at least by 48 hours to avoid fatigue accumulation. The day of the tests, the subjects 
were asked not to consume caffeine.  
 
2.3 First visit: Familiarization 
During the first session, anthropologic measures of body mass and height were measured. The 
participants were then informed about the protocol and the potential risks. Figure 1 describes 
the experimental design of this familiarization visit. Then, total blood occlusion or the pulse 
elimination pressure was measured. Subjects were seated on a chair while a pneumatic cuff 
(cuff size 11x85cm, bladder size 10x41cm) was placed on the right upper leg and connected 
to a cuff system (E20/AG101 Rapid Cuff Inflation System, D.E. Hokansson Inc., Bellevue, 
WA, USA). Air pressure in the cuff was gradually increased until the point at which blood 
flow was no longer present in the femoral artery. Using Doppler ultrasound, it was possible to 
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ensure that blood flow was completely occluded, and the total occlusion was reached when no 
pulse or blood flow was observed. This procedure was repeated two or three times for 
reliability and accuracy. The average of the measures was retained as the total occlusion 
pressure (Tocc) for each subject. In many studies, the occlusion level has been set at 220 
mmHg (Przyklenk K, 1993) (Clevidence M. W, 2012) (Gibson N, 2015) (Loenneke J. P., 
2011) however, some studies have reported that the femoral artery was not completely 
occluded at a pressure level of 250 mmHg (Iida H, 2007) (Sharma V, 2014). The leg 
circumference may influence pressure level to induce total arterial blood flow blockage (Iida 
H, 2007). Following these measurements, subjects were given an explanation on the different 
variables measured during the next four testing sessions such as oxygen uptake, muscle 
oxygenation via near-infrared spectroscopy (NIRS), arterial oxygen saturation, blood lactate, 
rating of perceived exertion of the legs and the breathing with the Borg scale, and heart rate. 
Afterward, subjects were seated on the bike (Lode Excalibur Sport Ergometer, Lode B.V., 
Netherlands). The bike was set for each subject and the dimensions recorded for use during all 
subsequent sessions.  
During this first session, the subjects were asked to perform a 3-min all-out test. This test is 
currently used to measure the critical power (CP). One method of estimating the heavy–severe 
domain boundary is to establish the CP which requires a subject to exercise to exhaustion at 
several constant work rates on separate days. The relationship between power output and time 
to exhaustion is hyperbolic and is defined by two parameters: CP, which represents the 
highest sustainable work rate and the curvature constant (W’), which is the maximum amount 
of work that can be performed (Vanhatalo A, 2007). D. Hill also defined the critical power, as 
“The basis of the critical power concept is that there is a hyperbolic relationship between 
power output and the time that the power output can be sustained. The intensities above CP is 
often referred to as anaerobic work capacity (Hill D.W, 2002). Vanhatalo have previously 
demonstrated that a 3-min all-out cycling test results in a highly reproducible power profile 
that levels out during the final 30–60 s at a power output approximately halfway between the 
lactate threshold (estimated by gas exchange indices) and the peak work rate attained in a 
ramp test. That is close to the power output at which the heavy–severe domain boundary 
would be expected to occur (Vanhatalo A, 2007). As stated previously , the 3-min test 
duration was chosen to provide a protocol that was long enough to yield a stable power output 
at the end of the test, but not so long that subjects would fail to complete the test (Vanhatalo 
A, 2007). 
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In the current study, the 85% of the CP was chosen for the sub-maximal test intensity. The 
subjects began with a warm up of five minutes at 50 W and five minutes at 100 W. During 
this warm up an explanation of the 3-min all-out test was given. The protocol of the 3-min all-
out test was the same as the study of Vanhatalo A, (2007). The test began with 3 minutes of 
unloaded baseline pedaling at each subject`s preferred cadence, followed by a maximal 3-min 
effort. Subjects were asked to increase the cadence during the last 5 s of the baseline period. 
The resistance on the pedals during the 3-min effort was set using the linear mode of the 
ergometer so that the subjects would attain the power output halfway between VO2 peak and the 
GET on reaching their preferred cadence (linear factor = power/ cadence squared). Strong 
verbal encouragement was provided throughout the test, although the subjects were not 
informed of the elapsed time, to prevent pacing. To ensure an all-out effort, subjects were 
instructed to maintain their cadence as high as possible at all times throughout the test 
(Vanhatalo A, 2007). At the end of the 3-min all-out test, the critical power (CP) was 
calculated as the mean power of the last 30 seconds. During the 3-min all-out test subjects 
wore a mask to measure the gas exchange (see section 2.5.4 oxygen uptake). 
 
 
Figure 1: Experimental design: Familiarization.	
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2.4 Protocol  
2.4.1 Warm-up 
 
Each test visit had the same structure, as illustrated by Figure 2. Subjects were equipped with 
all the materials (NIRS, HR monitor, oximeter), and began with a two-minute normalization 
resting period while sitting stationary on the bike. Following which subjects warmed up for 
five minutes at 50 W and five minutes at 100 W in order to provide a baseline for 
normalization of the NIRS. Subsequently, the mask to simulate the altitude (Everest Summit 
II Generator, Hypoxico Inc, New York, NY, USA) and the automatic cuffs were placed on the 
proximal most part of both legs to begin the preconditioning exercise.  
 
Figure 2: Experimental design: Test visits. 
 
2.4.2 Preconditioning: Four conditions 
 
Four conditions were tested:  
1. Control (C): Normoxia (400 m FIO2 20.9%) without occlusion (cuffs inflated at 30 
mmHg). 
2. Ischemic preconditioning (IPC): Normoxia with 60% of total occlusion. 
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3. Hypoxic preconditioning (HPC): At a simulated altitude (FIO2 13.6%) without 
occlusion (cuffs inflated at 30 mmHg). 
4. Hypoxic and Ischemic preconditioning (HIPC): At a simulated altitude (FIO2 13.6%) 
with 60% of total occlusion. 
 
2.4.3 Exercise period of the preconditioning  
 
The optimal number and length of occlusion-reperfusion cycles is unknown (Vanhatalo A, 
2007). Most of the studies investigating IPC followed the same model during the 
preconditioning session (Sharma Vikram , 2015) (Kjeld Thomas, 2014) (Przyklenk K, 1993) 
(Hausenloy D. J, 2010). The same procedure was thus replicated in the current study. 
Preconditioning consisted of four cycles of five minutes of cycling (with one of the four 
conditions as indicated above) alternated by five minutes of rest/reperfusion (passive seated 
rest on the bike). The intensity of cycling was the same in all stages and conditions, 
corresponding to a resistance of 1.5 W/kg. After each stage, participants indicated the rating 
of perceived exertion (RPE, 6 – 20; Borg scale) to represent the feeling in the legs and of the 
breathing. Studies on the IPC preconditioning recommended a cadence around 85 rpm during 
all the preconditioning (Moseley Luke, 2001). In the current study the subjects were also 
asked to pedal at 85 rpm during all the preconditioning conditions.  
 
2.4.4 Resting period between the preconditioning and the sub-maximal test 
 
As known from previous research, IPC induces an early (1-2h) and a late (12-72h) phase of 
effectiveness on ischemia-reperfusion injury (Incognito A. V, 2015). The time lag between 
the end of preconditioning and start of exercise performance ranged in general between 5-105 
minutes, however, the optimal time lag has not been thoroughly investigated (Faiss R, 2013). 
In the present study, the preconditioning session was followed by a thirty-minute break. The 
participants could rest and drink water while seated on a chair. A forty-minute period was 
taken between the end of preconditioning and the start of the sub maximal test. During this 
break, the gas exchange system (Quark CPET, Cosmed, Rome, Italy) was calibrated. Air 
volume was calibrated with a 3L calibration syringe and gases concentration with a standard 
air carboy (5.03% CO2, 15.06% O2 calibration gas, PanGas AG, Dagmersellen, Switzerland).  
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2.4.5 Sub-maximal test  
 
The sub-maximal test consisted of three trials of six minutes of cycling at 85% of the CP 
alternated by six minutes of rest. In previous research, authors used one exercise transition to 
calculate the pulmonary VO2 kinetics (Barbosa T.C, 2015).  Nevertheless, repetitions of 
exercise transitions are crucial to increase the signal-to-noise ratio (Barbosa T.C, 2015). 
Authors found that four to eight exercise bouts are used for moderate-intensity transitions and 
two to four exercise bouts are used for severe-intensity transitions (Poole David C, 2012). In 
the current study, with three bouts of exercise at 85% of CP, the subjects performed heavy 
intensity exercise. Subjects performed a standardized warm-up consisting of five minutes 
cycling at 100 W. After the warm-up, a break of 5 minutes was needed to set up the gas 
analyzer mask and to prepare the subjects for the trials. Subjects were asked to pedal with a 
cadence of 85 rpm during all trials. During the last 30s of each trial, the oxygen saturation 
was recorded from the fingertip. After each trial the RPE of the legs and the breathing were 
asked, and blood lactate sample from the earlobe measured. During the resting period, the 
subjects could pedal for two minutes with no resistance and then rest on the bike for four 
minutes to complete the recovery period. The gas analyzer mask was removed between trial 
two and three to let the subjects drink water ad libidum. During the exercise periods of the 
preconditioning and the sub-maximal test, the subjects were asked to remain in the same 
seated position on the bike and were not allowed to stand on the pedals. During the entire sub-
maximal test, NIRS, oxygen saturation, heart rate and gas exchanges were recorded. The heart 
rate HR was taken directly by the Quark CPET of Cosmed with a Garmin heart rate monitor 
during the sub-maximal exercise (HRM Run Heart Rate Strap, Garmin, Kansas, USA).	The variables	measured	were: 
• Lactate measured in [mmol-l]  
• Heart rate (bpm)  
• Finger and earlobe oxygen saturation (%) 
• RPE [6-20]: (leg and breathing)  
• VO2 
• Muscle oxygenation with near-infrared spectroscopy (NIRS) 
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2.5 Analysis 
2.5.1 Heart rate 	
Heart Rate was monitored at 5 Hz by telemetry during the preconditioning with a heart rate 
monitor (Polar RS400, Kempele, Finland). The data were then downloaded on Polar Pro 
Trainer 5 software. Files from Polar Pro Trainer 5 were then extracted and saved as excel 
documents. Illustrated in Figure 3, mean of the last minute of each cycle (4 cycles) was 
calculated. The mean of each end cycle value also was calculated as an average for the 
condition. During the three trials of the sub-max test, the HR was monitored at 1 Hz by 
telemetry with a heart rate monitor (Garmin) directly monitored by the gas exchange system 
(Cosmed, as described above). As illustrated in Figure 4, the mean of the heart rate of each 
trial (3 trials) was calculated. The mean of each end cycle value was also calculated. 
 
 
Figure 3: Illustration of heart rate (bpm) during warm-up and the preconditioning. 	
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Figure 4: Illustration of heart rate (bpm) during the three trials of the sub-maximal test. 	
2.5.2 Finger oxygen saturation (%)  	
At the end of each preconditioning cycle (during the last 30 s of each stage), finger oxygen 
saturation (%) (8000SM Sensor, Nonin Medical Inc., Amsterdam, The Netherlands) was 
measured on the forefinger of the right hand, as well during the sub-maximal trials.  
 
2.5.3: Blood lactate  	
Blood lactate concentration (mmol-1) was measured with an automated system (Lactate Scout, 
SensLab, GmbH, Leipzig, Germany). The right earlobe was cleaned and pricked, thus taking 
a small droplet into the strip for analysis. Lactate was measured at 1 minute after the 
termination of the preconditioning session. The procedure was repeated at the end of each 
trial of the sub-maximal test.  
 
2.5.4: Oxygen uptake 	
Oxygen uptake consumption was recorded during the sub-maximal test using a gas analyzer 
(Quark CPET, Cosmed, Rome, Italy). The signals were recoded with the “Breath by breath” 
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mode in the software. Subjects were fit with a mask and cables were carefully suspended to 
avoid excess movement during sprints. Concerning the analysis, the values were exported in 
Excel, and an average was calculated during the last minute of each sub-maximal trial.  Figure 
5 below shows an example of the VO2 evolution during the sub maximal test. Data were 
transferred in excel files to run a macro. The macro allowed investigation of the amplitude, 
time delay, and time constant of the O2 kinetics. Several models have been proposed to 
describe the VO2 kinetics.  For primary analysis, we used the exponential model.  
VO2	(t) = VO2	b 
 + A1 [1 - e – [(t - td1)/ 1] U1 Phase 2 (primary component) 
+ A2[1 - e- [ (t - td2)/ 2] U2 Phase 3 (slow component) 
where U1  = 0 fort < td1 and U1 = 1 for t ≥ td1, and U2 = 0 for t < td2 and U2  = 1 for t ≥ td2.	VO2	b is the VO2 at rest; A1 and A2 are the asymptotic amplitudes for the second and third 
exponential, respectively; τ 1 and τ 2 are the time constants of each exponential; and td1 and td2 
represent the time delays of each equation.  
The amplitude of slow component was assigned the value 
A’2  = A2 [1 - e – [ (te - td2)/ 
τ2]] 
where te is the time at end of exercise. 
As pointed out by Linnarsson (1974), when the second exponential component has a time 
constant that is substantially longer than the duration of the data collection, it is indistin- 
guishable from a linear “drift.” If this case appears, the linear model proposed by Paterson 
and Whipp and colleagues (Paterson DH, 1991) (Whipp BJ, 1970) would be used. 
The parameters of the model were determined with an iterative procedure by minimizing the 
sum of the mean squares of the differences between the estimated VO2 based on the model and 
the measured VO2 . Values of the measured VO2  that were greater than three standard 
deviations from the VO2 of the model were considered outliers and were removed. These 
outlier values were assumed to be due to abnormal breaths during exercise, such as shallow 
breathing or breath holding. These values represented <1% of the total data collected. 
Iterations continued until successive repetitions reduced both the sum of residuals by <108 and 
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the correlation coefficient of the relationship between residuals and time by <106. The 
bootstrap method was used to test the confidence interval of the model parameters. This 
method estimates the potential error in the determination of model parameters using repeated 
samples from the original data set. 
During the current study, the gross efficiency (GE), work efficiency (WE), net efficiency 
(NE), energy cost (EC) and Energy expendure (EE) were mesured. GE, WE and NE were 
calculated from measures of energy expended, VO2  and work rate. Energy expended (EE) 
was calculated from the measures of VO2  and VCO2  obtained from the gaz alalyser and 
analyzed using the formula of Brouwer. 
 
Energy Expenditure (J.s-1) 
[(3.869 × V ̇ O2) + (1.195 × V ̇ CO2)] × (4.186/60) × 1000 
GE was calculated as the mean of all data collected in the last 2 min of every work rate over 
and including 95 W and until the respiratory exchange ratio exceeded 1.00 
GE(%) = (Work Rate(W))/Energy Expended (J . s-1) ×	100% 
EC was calculated as the power output divided by the rate of oxygen consumption and 
expressed as kJ·L -1. 
The RER was directly calculated by the gas analyzer system. The system gave us the direct 
values.  
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Figure 5: VO2 (ml/min) during the three trials of the sub-maximal test.  	
2.5.5: Muscle oxygenation  
 
Muscle oxygenation was measured using the near infrared spectroscopy (NIRS) technique 
explained by Boushel R, (2000). Near-infrared spectrometry (NIRS) is a non-invasive 
technique permitting to calculate tissue concentrations in oxyhemoglobin ([OⁿHb]), 
desoxyhemoglobin ([HHb]), total hemoglobin ([tHb]), and tissue saturation index (TSI %). 
This technology uses light that is transmitted through body’s skin, muscle, and adipose tissue. 
Light absorption is measured and calculated with a modified form of the Beer-Lambert-Law. 
This law gives us [OⁿHb], [HHb], [tHb] and TSI based on the amount of light that is absorbed 
or reflected into the device as an indication of the concentration of each variable. A previous 
study has reported that [OⁿHb] values were more sensitive to blood changes than [HHb] 
(Delpy D. T, 1997). The TSI is the oxygenation tissue index; it’s an estimation of the oxygen 
tissue saturation (StOⁿ) in percentage. The StOⁿ is the concentration of OⁿHb in relation with 
the total of hemoglobin; it’s an absolute parameter (Patterson MS, 1989). The TSI reflect the 
dynamic balance between the Oⁿ income troughs the muscular circulation and the 
consummation of Oⁿ by the muscles (Delpy DT, 1997). 
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A PortaMon NIRS device (PortaMon, Artinis, Zetten, The Netherlands) was placed on the 
right vastus lateralis (VL) to measure muscle oxygenation. The PortaMon device was 
carefully covered in a transparent plastic wrap to avoid humidity and maintain a waterproof 
barrier for the device’s function. The PortaMon was attached to the leg with a standard 
bandage with a bit of tension to allow as little movement as possible during contractions and 
taped to the skin to assure its good stability and avoid any movement during cycling. This 
bandage also created a dark environment, which improved the quality of the NIRS recording. 
A NIRS PortaMon was recording during the entire duration of each test. Using a permanent 
pen, probe placement was precisely marked along all test visits to assure same position 
placement during each visit, and subjects were asked to keep the mark throughout the 
duration of the study.  
All signals were recorded with a sampling frequency of 50 Hz (Oxysoft 3.0.53, Artinis, The 
Netherlands). Data were down sampled to 10 Hz during the exportation and at 10Hz during 
the analysis using excel macros. For the analysis, the macro indicated the delta of each of the 
three variables normalized to the warm-up. The purpose to normalize with the warm-up 
values was to allow a comparison of the change in values, as it is an arbitrary concentration. It 
also allows greater constituency and variation as a way to compare between subjects. We 
analyzed the PC and sub-maximal test in the same way. Each delta variable corresponds to an 
average value of the final 60 seconds of each PC stage or sub-maximal trial that has been 
normalized against the difference of the averages of the last 30 seconds of the 100W and 50W 
stages performed at the start of the testing visit each day. In details the normalization value is 
the average of the last 30 sec of the warm-up 100 W minus the average of the last 30 sec of 
the warm-up 50 W. Then the average of the last 60 sec of the PC or sub-maximal is 
normalized by this normalization value.  
The equation is: (last 60sec average of PC or Sub – normalized value) / normalized value. 
 
2.5.6 Statistical analysis 	
All results are presented as mean ± standard deviation (SD) on graphs. Interactions do not 
appear on the graphs due to lack of space. For the preconditioning phase and the sub-maximal 
test two kinds of statistic were performed with Sigmastat (SigmaStat 3.5, Systat Software, San 
Jose, California, USA). One-way repeated measures ANOVA [condition (C, IPC, HPC and 
HIPC)] was applied on the mean of each end cycle value of every parameter. During 
	 25	
preconditioning and the sub-maximal test, a two-way repeated measures ANOVA was also 
applied on the values of each end cycle of every parameter. During the sub-maximal test, a 
one way repeated measures ANOVA was applied on the mean of the last minute of the first 
trial. Due to some missing data, statistical analysis was performed with SPSS for 
preconditioning NIRS values, using a mixed model developed by Fabienne Crettaz Von 
Roten. All statistical results were rejected under a significant value < 0.05. Strong 
significance was set < 0.001.   
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3. Results 
 
3.1 Familiarization 
 
Table 1 shows the different characteristic parameters of initial measurements.  
 
ID subject Body mass Preconditioning 
intensity 
Body height Total occlusion  60% occlusion  
 kg W cm mmHg mmHg 
1 55.5 
 
83 159 222 133 
2 71.2 107 180 187 112 
3 
 
72.8 109 185.5 182 109 
4 60.7 91 168.6 166 100 
5 57.7 87 170.9 204 122 
6 81.9 123 193.2 188 113 
7 71.6 107 181 223 134 
8 90.7 136 200 195 117 
9 63.7 96 170.5 175 105 
10 77.7 117 183.5 194 116 
11 76.6 115 187.5 198 119 
12 70.6 106 177.8 239 143 
13 66.4 100 168.3 168 101 
14 88.6 133 188 223 134 
Mean 71.84 108 179.56 197.43 118 
SD 11 16 11 22 13 
Table 1: Subjects information’s 	
Mean ± SD: Mean of all subjects 
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Table 2 shows the results of the three-min all-out test. This data were used to set the intensity 
of the sub-maximal test.  
 
 Critical power 30 last seconds 
Submaximal 
intensity 
Average power 3 
min all out  
Peak power 3 min 
all-out 
 W W W W 
Mean 250 212 343 1157 
SD 74 63 79 231 
 
Table 2: Subjects results for the three minutes all-out test. 	
Mean ± SD: Mean of all subjects 
 
Figure 6 represents the evolution of the power during the 3-min all-out test.  
Figure 6: Evolution of the power (W) during the 3-min all-out test. 	
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3.2 Preconditioning 
3.2.1 Physiological responses 
 
During the preconditioning and the sub-maximal test the data of the oxygen saturation from 
the earlobe was not analyzable. It was impossible to interpret this data.  
Figure 7 shows heart rate (HR) during preconditioning cycles. HR was lower in control 
condition than in IPC (P = 0.006), HPC and HIPC (P <0.001).  HPC and IPC condition 
showed lower HR than HIPC (P <0.001). There was no difference in HR between conditions 
IPC and HPC. 		
	
 
Figure 7: Heart rate  (HR) during preconditioning. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). && <0.01, &&& <0.001 for difference with C, ^^^ <0.001 for difference with 
IPC,!!! <0.001 for difference with HPC.  
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Figure 8 illustrates the peripheral oxygen saturation (SpO2) during preconditioning. There was 
no difference between the IPC and the control condition. The control condition and IPC show 
better oxygen saturation than HPC and HIPC condition (P <0.001).  The percentage of 
oxygen saturation of HIPC was also higher than HPC (P= 0.008). 
 
 	
Figure 8: Oxygen saturation (SpO2) during preconditioning. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). &&& <0.001 for difference with C, ^^^ <0.001 for difference with IPC, !! 
<0.01 for difference with HPC. 
 
Figure 9 shows the rate of perceived exertion (RPE) of the legs during preconditioning. The 
occlusions conditions (IPC and HIPC) increase the RPE of the leg in comparison with the 
control and HPC conditions (P <0.001). There was no difference between the control 
condition and HPC, as well as no difference between the IPC and HIPC.  
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Figure 9: Rate of perceived exertion of the legs during preconditioning. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). &&& <0.001 for difference with C, ^^^ <0.001 for difference with IPC, !!! 
<0.001 for difference with HPC. 
 
Figure 10 shows rated perceived exertion of the breathing. There were no differences between 
the control, IPC, and HPC conditions. HIPC increased the RPE of the breathing in 
comparison with all others conditions (P <0.001).  
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Figure 10: Rated perceived exertion of the breathing during preconditioning. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). &&& <0.001 for difference with C, ^^^ <0.001 for difference with IPC, !!! 
<0.001 for difference with HPC. 
 
Figure 11 shows the blood lactate concentration (Lac) immediately following the last stage of 
the preconditioning. There was no difference between the control condition and HPC, or 
between IPC and HIPC. The control condition was lower than the IPC and HIPC conditions 
(P = 0.005 and P <0.001). Lactate in HPC was also lower than in HIPC (P = 0.018). 
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Figure 11: Lactate (Lac) during preconditioning. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). && <0.01, &&& <0.001 for difference with C, ! <0.05 for difference with 
HPC. 
 
 
3.2.2 Muscle oxygenation 	
For all the four parameters delta desoxyhemoglobin (ΔHHb), delta oxyhemoglobin (ΔO2Hb), 
delta total hemoglobin (ΔtHb) and delta tissue saturation index (ΔTSI (%)), there was no 
difference between the conditions with a one-way ANOVA. To continue to analyze the data, a 
two-way repeated measures ANOVA with condition x stage was used.  
 
 
Figure 12 shows the ΔHHb during preconditioning. There was no significant difference 
between the conditions and the stages.  
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Figure 12: ΔHHb normalized during preconditioning. 
Mean ± SEM: Mean of all subjects by condition and stage. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).  
Stages:  Stage 1, Stage 2, Stage 3, and Stage 4. 
 
Figure 13 shows ΔO2Hb during preconditioning. IPC condition had a lower concentration of 
O2Hb than the control (P= 0.02), HPC (P <0.001), and HIPC (P <0.001) conditions. There 
was no difference between control, HPC, and HIPC conditions. In addition, there was no 
difference between the stages in any condition.  
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Figure 13:  ΔO2Hb normalized during preconditioning. 	
Mean ± SEM: Mean of all subjects by condition and by stage. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ^ <0.05, ^^^<0.001 for difference with IPC 
Stages:  Stage 1, Stage 2, Stage 3, and Stage 4.  
 
Figure 14 shows ΔtHb during preconditioning. The HIPC condition had a lower concentration 
of ΔtHb than the IPC condition (P = 0.018).  There was no difference between the other 
conditions. In all conditions stages 3 and 4 had higher concentration of ΔtHb than stage 1 (P 
<0.001). There was no difference between the first and second stage.  
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Figure 14:  Δ tHb normalized during preconditioning. 
Mean ± SEM: Mean of all subjects by condition and by stage. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ^ <0.05 for difference with IPC. 
Stages:  Stage 1, Stage 2, Stage 3, and Stage 4. *** <0.001 for difference with stage 1. 
 
 
Figure 15 shows the Δ TSI (%) during the preconditioning. All stages had a lower percentage 
of Δ TSI in IPC than in the control condition (P= 0.028). There was no difference between the 
other conditions. In all conditions, stages 3 and 4 had higher percentages of Δ TSI than stage 
1 (P  <0.001). There was no difference between the other stages.  
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Figure 15:  TSI normalized during preconditioning. 
Mean ± SEM: Mean of all subjects by condition and by stage. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). & <0.05 for difference with C. 
Stages:  Stage 1, Stage 2, Stage 3, and Stage 4. *** <0.001 for difference with stage. 
 
3.3: Sub maximal performance 
During the sub-maximal test, the HR, SpO2, RPE_L, RPE_B, blood lactate, VO2, and NIRS 
were measured.  
 
3.3.1: Physiological responses 	
Figure 16 shows the HR during the three trials of the sub maximal performance. HR was 
higher with HPC than with IPC (P = 0.067). There was no difference between the other 
conditions.  
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Figure 16: Hart rate by condition (HR) during sub-maximal test. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ^ < 0.05 for difference with IPC. 
 
 
Figure 17 shows the RPE of breathing during the three trials of the sub-maximal performance. 
The HIPC condition was lower than HPC (P = 0.037). There was no difference between the 
other conditions. 
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Figure 17: Rated perceived exertion of the breathing (RPE_B) during sub-maximal test. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ! < 0.05 for difference with HPC.  
 
Table 3 represents the results of the gross efficiency (GE), the energy cost (EC), the energy 
expenditure (EE) and the respiratory exchange ratio (RER). 
 Condition 1 Condition 2 Condition 3 Condition 4 Significance 
GE (%) 19.4%	 ± 1%	
 		19.5%	± 1%	 19.3%	± 2%	
	
19.4%	 ± 1%	
 
NO 
EC (kj/L) 4.12	± 0.3	 4.14 ± 0.3 4.1 ± 0.35 4.12 ± 0.3 NO 
EE (J/s) 1086 ± 270  
1077 ± 269 
 
1091 ± 268 
 
1085 ± 278 
 NO 
RER 1.01 ± 0.05 1.01 ± 0.05 1.01 ± 0.05 1 ± 0.07 NO 
 
Table 3: Gross efficiency, energy cost, energy expenditure and respiratory exchange ratio. 
Mean ± SD : Mean of all subjects by condition 
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Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).	
3.3.2: VO2 kinetics 
 
Figure 18 shows the time constant of the VO2 kinetics. CT1 was slower with HPC condition 
than with the control condition (P = 0.047). There was no difference between the other 
conditions or trials. 
 
 
 
Figure 18:  Time constant of the VO2 kinetics during the sub-maximal performance. 
Mean ± SEM: Mean of all subjects by condition and by trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). & <0.05 for difference with C. 
Trials:  Trial 1, Trial 2, and Trial 3. 
 
 
Figure 19 shows the time constant of the VO2 kinetics during the first trial of the sub-maximal 
performance. The time constant with HPC was slower than with the control condition (P = 
0.014). There was also a difference between HPC and HIPC conditions. The HPC condition 
was also slower (P = 0.014) than HIPC. There was no difference between the other 
conditions.  
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Figure 19:  Time constant of the VO2 kinetics during the first trial of sub-maximal performance. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). & <0.05 for difference with C, ! < 0.05 for difference with HPC.  
 
3.3.3: Muscle oxygenation kinetics 
 
Figure 20 shows the time constant of the O2Hb kinetics. CT1 of the O2Hb was faster with the 
HIPC condition than with the IPC condition (P = 0.039). There was no difference between the 
other conditions or trials.  
 
	 41	
 
Figure 20:  Time constant of the O2Hb kinetics during the sub-maximal test. 
Mean ± SEM: Mean of all subjects by condition and by trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ^ <0.05 for difference with IPC. 
Trials:  Trial 1, Trial 2, and Trial 3. 
 
Figure 21 shows the time constant of the oxyhemoglobin (O2Hb) kinetics of the first trial of 
the sub-maximal exercise. CT1 was faster with the HIPC condition than with the IPC 
condition (P = 0.024). There was no difference between the other conditions.  
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Figure 21:  Time constant of the O2Hb kinetics during the first trial of the sub-maximal test. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ^ <0.05 for difference with IPC. 
 
 
Figure 21 shows the time constant of the desoxyhemoglobin (HHb) kinetics during the first 
trial of the sub-maximal exercise. There was a difference between the HPC and HIPC 
conditions. The HPC time constant is faster than HIPC (P = 0.039). There were no differences 
between the other conditions.  
 
 
Figure 21: Time constant of the HHb kinetics during the first trial of the first sub-maximal exercise. 
Mean ± SEM: Mean of all subjects by condition. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). ! <0.05 for difference with HPC. 
 
3.3.4: Muscle oxygenation end trials 
 
The concentration of delta desoxyhemoglobin (ΔHHb) during the last minute of each trial of 
the sub-maximal test is represented in figure 22. Control and HIPC conditions had lower 
concentrations of delta HHb than with HPC (P <0.001), and IPC also had lower ΔHHb than 
HPC (P = 0.003). There was no difference between the trials. 
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Figure 22:  The concentration of ΔHHb during the last minutes of each trial of the sub-maximal exercise.  
Mean ± SEM: Mean of all subjects by condition and trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC). !! <0.01,!!! <0.01 for difference with HPC. 
Trials: Trial 1, Trial 2, and Trial 3. 
 
 
Figure 23 shows the concentration of delta oxyhemoglobin in the last minute of each trial of 
the sub-maximal exercise. The ΔO2Hb with IPC was lower than with the control, HPC, and 
HIPC conditions (P = 0.01, P = 0.03, P <0.001). There was less ΔO2Hb with the IPC 
condition at the end of each trial. 
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Figure 23:  The concentration of ΔO2Hb during the last minutes of each trial of the sub-maximal exercise.  
Mean ± SEM: Mean of all subjects by condition and trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).  ^ <0.05, ^^ <0.01, ^^^ <0.01 for difference with IPC. 
Trials: Trial 1, Trial 2, and Trial 3. 
 
 
Figure 24 represents the concentration of delta total hemoglobin (ΔtHb) during the last 
minute of each trial of the sub-maximal exercise. There was more concentration of ΔtHb with 
IPC than with the control (P = 0.059) and also more ΔtHb with IPC than with HIPC (P = 
0.01). There were no differences between the other conditions or trials. 
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Figure 24:  The concentration of ΔtHb during the last minutes of each trial of the sub-maximal exercise.  
Mean ± SEM: Mean of all subjects by condition and trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).  ^ <0.05, ^^ <0.01 for difference with IPC. 
Trials: Trial 1, Trial 2, and Trial 3. 
 
 
Figure 26 shows the delta tissue saturation index during the last minute of each trial of the 
sub-maximal exercise. The ΔTSI (%) was higher with HPC conditions than with IPC and 
HIPC (P = 0.025, P = 0.088). Trial 3 was higher than trial 1 (P <0.001) and higher than trial 2 
(P = 0.045). Trial 2 was also higher than trial 1 (P = 0.051).  
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Figure 26:  The ΔTSI (%) during the last minutes of each trial of the sub-maximal exercise.  
Mean ± SEM: Mean of all subjects by condition and trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).  ! <0.05, for difference with HPC. 
Trials: Trial 1, Trial 2, and Trial 3. * <0.05, *** <0.001 for difference with 1, “ <0.05 for difference with 2. 
 
 
3.4 Summary of the results  
Table 4 shows a summary of the different parameters of the physiological responses during 
the four stages of the preconditioning.  
 
Parameter 
Condition 
difference 
Trial 
difference 
Significance Stages 
Heart rate (bpm) Yes Yes 
Con: <0.001 
Sta <0.001 
Con: C vs HIPC, IPC vs HIPC, 
HPC vs HIPC (P= <0.001) 
andC vs IPC (P= 0.006) 
Sta : 1 vs 3, 1 vs 4 (P= <0.001) 
and 1 vs 2 (P= 0.002) 
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O2 saturation (%) Yes No <0.001 
 
C vs HPC, C vs HIPC, PC vs 
HPC, IPC vs HIPC (P= 
<0.001) and HPC vs HIPC (P= 
0.008) 
 
RPE leg Yes Yes 
Con: <0.001 
Sta: 0.002 
 
Con : C vs IPC, C vs HPC, C 
vs HIPC and IPC v HIPC (P= 
<0.001) 
Sta : 1 vs 4 (P= 0.003)and 2 vs 
4 (P= 0.032) 
	
RPE breathing Yes Yes 
Con: <0.001 
Sta: 0.002 
 
Con: C vs IPC, C vs HPC and 
C vs HIPC (P= <0.001) 
Sta : 
1 vs 3 (P= 0.009), 2 vs 4 (P= 
0.026) and 1 vs 4 (P= <0.001) 
 
Lactate (lac) 
Post stage 4 
Yes X <0.001 
 
C vs HIPC (P= <0.001), HPC 
vs HIPC (P= 0.018) and C vs 
IPC (P= 0.005) 
 
 
Table 4: Summary of the physiological responses during the four stages of the preconditioning.  	
Mean ± SEM: Mean of all subjects by condition and stage. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).   
Stages: Stage 1, Stage 2, Stage 3, and Stage 4. 
 
 
 
Table 5 represents a summary of the different parameters of muscle oxygenation during the 
four stages of the preconditioning. 
Parameter 
Condition 
difference 
Trial 
difference 
Significance Stages 
Δ HHb last minute No No   
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Δ O2Hb last minute Yes No <0.001 
 
IPC vs HPC, IPC vs HIPC (P= 
<0.001) and C vs IPC (P= 
0.02) 
 
 
Δ tHb last minute 
 
Yes 
 
No 
 
0.018 
 
IPC vs HIPC (P= 0.018) 
 
Δ TSI (%) last minute Yes Yes 
Con: 0.028 
Sta: <0.001 
 
Con: C vs IPC (P= 0.098) 
Sta : 
1 vs 3 and 1 vs 4 (P= <0.001) 
 
 
Table 5: Summary of muscle oxygenation during the four stages of the preconditioning.  	
Mean ± SEM: Mean of all subjects by condition and stage. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).   
Stages: Stage 1, Stage 2, Stage 3, and Stage 4. 
 
 
Table 6 shows a summary of the different parameters of the physiological responses during 
the tree trials of the sub-maximal exercise. 
Parameter 
Condition 
difference 
Trial 
difference 
Significance Trial 
 
Hart Rate (bpm) 
 
Yes 
 
Yes 
 
Con: 0.044 
Tri: <0.001 
Con: IPC VS HPC (P= 0.067) 
Tri: 1 vs 2, 1 vs 3, 2 vs 3 (P= 
<0.001) 
O2 Saturation (%) No Yes 0.032 1 vs 3 (P= 0.033) 
RPE leg (6-20) No Yes <0.001 
1 vs 2 (P= 0.007) and 1 vs 3 (P= 
<0.001) 
RPE breathing (6-20) No Yes <0.011  
Lactate (Mmol/L) No Yes <0.001 1 vs 2, 1vs 3 and 2 vs 3 
Energy Cost (Kj/I) No Yes 0.008 1 vs 3 
Gross constant power 
(W/Kg) 
 
No 
 
No 
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Extern efficiency (%) No No   
Respiratory quotient No Yes <0.001 1 vs 2, 1vs 3 and 2 vs 3 (0.008) 
CO2 volume (ml/min) No Yes <0.001 1 vs 2 and 1 vs 3 
O2 volume 
(ml/Kg/min) 
 
No 
 
Yes 
 
0.008 
1 vs 3 
VE (L/min) No Yes <0.001 1 vs 2, 1 vs 3 and 2 vs 3 (0.009) 
VO2 A1 No Yes 0.003 1 vs 3 
VO2 TD1 (sec) No Yes 0.043 1 vs 2 
VO2 CT1 (sec) Yes No 0.047 C vs HPC 
 
Table 6: Summary of the physiological responses during the tree trials of the sub-maximal exercise. 
  
Mean ± SEM: Mean of all subjects by condition and trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).   
Trials: Trial 1, Trial 2, and Trial 3. 
 
 
Table 7 represents a summary of different parameter of the muscle oxygenation during the 
three trials of the sub-maximal exercise.  
 
 
Parameter Condition 
difference 
Trial 
difference 
Significance Trials 
HHb A1 No No   
O2Hb A1  No No   
TSI A1 No No   
HHb TD1 (sec) No No   
O2Hb TD1 (sec) No No   
TSI TD1 (sec) No No   
HHb CT1 (sec) No Yes 0.0023 1 vs 2 
O2Hb CT1 (sec) Yes No 0.0039 IPC vs HPC 
TSI CT1 (sec) No No Trend  IPC vs HPC (P =0.051) 
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Δ HHb last min  
 
Yes 
 
No 
 
<0.001 
 
C vs HPC, HPC vs HIPC and IPC 
vs HPC (P = 0.004) 
 
 
Δ O2Hb last min  
 
Yes 
 
No 
 
<0.001 
 
C vs IPC (P = 0.01), IPC vs HPC 
(P = 0.003) and IPC vs HIPC  
 
 
Δ tHb last min  
 
Yes 
 
No 
 
0.002 
 
C vs IPC (P= 0.057 and  IPC vs 
HIPC (P = 0.01) 
 
 
 
Δ TSI (%) last min 
 
 
Yes 
 
 
Yes 
 
Con = 0.011 
Tr = <0.001 
 
Con :  
IPC vs HPC (P= 0.025), HPC vs 
HIPC (P= 0.088) 
Trial :  
1 vs 2 (P= 0.051), 1 vs 3 (P= 
<0.001), 2 vs 3 (P= 0.045)	
 
Table 7: Summary of the muscle oxygenation parameters during the tree trials of the sub-maximal 
exercise.  
 
Mean ± SEM: Mean of all subjects by condition and trial. 
Conditions: Control (C), Ischemic preconditioning (IPC), Hypoxic preconditioning (HPC), Hypoxic and 
ischemic preconditioning (HIPC).   
Trials: Trial 1, Trial 2, and Trial 3. 
4: Discussion  	
The main result of the present study was that preconditioning (PC), whether ischemic or 
hypoxic, did not induce a potentially ergogenic effect on the sub-maximal performance. None 
of the physiological responses were improved during the sub-maximal performance (HR, 
SpO2, lactate, VO2, and work efficiency) Ischemic or hypoxic PC also did not lead to an 
enhancement in the VO2 kinetics. The time constant was not faster in any of the conditions in 
comparison with the control condition. In fact, the HPC condition was detrimental for the 
time constant witch was slowed. For the HIPC condition, the addition of the ischemic and the 
hypoxic preconditioning also had no supplementary effect on the sub-maximal performance 
than the hypoxic / ischemic conditions on their own. An interesting finding is that when the 
ischemia was added to the hypoxia during the PC, it seems to blunt the negative effect of the 
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hypoxia on the HHb during the sub-maximal test. Result of interest is the hyperemic effect of 
IPC as shown by the increase in tHb during the sub-maximal bouts.  
 
4.1: Three-minute all-out test 
Subjects were asked to perform a three-minute all-out test to measure the critical power (CP). 
During this test, subjects performed maximally with no pacing for three minutes with strong 
verbal encouragement. It is never sure that subjects do not pace the test, but with the verbal 
encouragement, the results were as expected.  
4.2: Preconditioning 
4.2.1: Ischemic condition (IPC) 	
Researchers have studied the cardiovascular functions associated with blood flow restriction 
(BFR) and have found that even at walking intensity, exercise with BFR induced an increase 
of HR (Renzi C.P, 2010). In the present study, IPC improved the HR (P = 0.006) in 
comparison with the control condition. This finding demonstrated that the cardiovascular 
work is enhanced during BFR. This has also been confirmed by Neto et al (2016) who found 
that exercise with BFR induced an increase of cardiovascular work (Neto G. R, 2016). 
Another study found that oxygen saturation decreased with exercise with BFR (Abe T, 2006). 
On the contrary, in the current study there were no differences between the control and IPC. 
In addition, the BFR did not seem to have an impact on the SpO2. In the same study (Abe T, 
2006), RPE was higher during BFR exercise, which is in accordance with the present study. 
RPE of the legs was lower in the control condition than in IPC and HIPC (P <0.001). The 
altered supply of intramuscular oxygen, which induces a more acidic and anabolic 
environment, likely affected the participants’ perceived exertion (Abe T, 2006). The increase 
of the blood lactate concentration also demonstrates that the environment is more acidic. 
Indeed, the results indicated that IPC and HIPC conditions had a higher lactate level (P = 
0.005, P <0.001). In a study exploring the Kaatsu training in walking, the lactate 
concentrations were also higher after BFR exercise (Engelen Arielle, 1996). The 
improvement of the blood lactate (a lower concentration) as well as lower HR can also 
influence the increase leg rating of perceived exertion. During BFR exercise, systolic and 
diastolic blood pressure increases while stroke volume decreases due to limited venous return, 
this could also create discomfort and increase the RPE of the leg (Engelen Arielle, 1996). 
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There was no difference in the conditions for the RPE in the breathing, meaning that BFR 
does not seem to directly affect the ventilatory system.  
For the muscle oxygenation, previous research has indicated that BFR during exercise creates 
a rapid depletion of O2 stores within muscle tissue (Hampson Neil B, 1998), which provokes a 
greater deoxygenation. In the current study, there were no differences in ΔHHb between any 
the conditions. However, regarding the ΔO2Hb, IPC was lower than C, HPC and HIPC (P = 
0.02, P <0.001). The ΔO2Hb was lower in IPC meaning that the subjects had less O2 to use, 
but there were no differences in the HHb, and thus changes on the depletion of O2 stores 
within the muscle tissue. For the ΔtHb, IPC was higher than HIPC (P = 0.018) but there was 
no difference with the control condition. This means that in the current study there was only a 
difference in ΔO2Hb that demonstrated the effects of an ischemic exercise. Compared to the 
control condition, IPC had a lower Δ percentage of tissue saturation (P = 0.028), which also 
demonstrated that during BFR exercise the O2 availability in the muscle was diminished. 
 
4.2.2: Hypoxic condition (HPC) 
In the current study, HPC presented a higher HR than the control condition. This finding is 
congruent with a study that also found that HR was higher in hypoxic conditions (Engelen 
Arielle, 1996). SpO2 in the HPC condition was also lower than in the control condition (P 
<0.001), as expected. The subjects were under normobaric hypoxic conditions meaning that 
the barometric pressure was the same as the see level but the fraction of O2 inspired (FIO2) 
was reduced by the hypoxia training device. When subjects were exercising in hypoxia 
conditions there was a decrease in oxygen saturation and to counter this decrease there was an 
increase the blood flow (Engelen Arielle, 1996), which can be illustrated in the present study 
by the increase in HR. HPC also had a higher RPE in the legs than the control condition  (P 
<0.001), however, the lactate concentration was not different than in the control. In a previous 
study, no differences were found in blood pH (Kubota Y, 2015); therefore, the decrease of the 
pH cannot be an explanation for the increase of RPE_L. The decrease of the oxygen 
saturation and therefore the lack of O2 in the muscle can stimulate an increase in the RPE_L. 
The increase of RPE_L in HPC was lower than IPC and the HIPC condition (P <0.001). 
Interestingly, even though the SpO2 decreases in HPC, there were no differences between the 
conditions for SpO2, meaning that in hypoxia exercise at the FIO2 of 13.6% does not cause an 
increase of the pulmonary ventilation to increase RPE_B. The current study found no 
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differences with RPE_B during any conditions. Previous literature indicated that in order to 
maintain O2 delivery during hypoxic ( FIO2 = 11%) exposure, pulmonary ventilation increases 
(Hammond M.D, 1986). In the current study, the simulated altitude was maybe not enough to 
see some influence of increased of pulmonary ventilation to have an effect on the RPE_B. For 
the muscle oxygenation there were no differences between HPC and the other conditions for 
ΔHHb, ΔO2Hb, and ΔtHb. The hypoxia induced during the exercise did not seem to provoke 
a muscle deoxygenation. ΔTSI (%) is also not different in the control condition and the HPC, 
which confirm the previous results.  
 
4.2.3: Ischemic and hypoxic condition (HIPC) 	
Studies have found that during BFR and during hypoxia exercise HR increases (Renzi C.P, 
2010) (Engelen Arielle, 1996). The present study shows that HR was much higher in HIPC 
condition than in the control condition (P <0.001). When BFR was combined with a reduction 
of the FIO2, there was a greater increase the cardiovascular work. In the current study, SpO2 in 
HIPC was lower in comparison with the control condition and IPC (P <0.001). This result 
confirms the fact that SpO2 decreases during hypoxia exercise (Engelen Arielle, 1996). An 
interesting finding is that SpO2 of HIPC was higher than HPC, meaning that the addition of 
the BFR to the hypoxia seems to further decrease the SpO2. BFR seems to blunt the 
detrimental effect of the hypoxia on the SpO2. The mechanism behind this phenomenon is 
unknown for the moment. The RPE_L was higher in HIPC than in C and HPC (P <0.001) but 
was not different with IPC. This result demonstrated that BFR was creating the most 
discomfort for the legs. RPE breathing in the HIPC condition was higher than C, IPC, and 
HPC (P <0.001), as well as no differences between C, IPC, and HPC conditions were found. 
The addition of the BFR and hypoxia provoked an overloading of the physiological responses 
of the body. In this case, the unchanging RPE_B in causing by hypoxia in HPC is in HIPC 
added to the BFR and thus an increase of RPE_B.  
For the muscle oxygenation, there were no differences in ΔHHb between HIPC and the other 
conditions, but ΔO2Hb was higher with HIPC than IPC (P <0.001). This result was curious 
since the greater muscle deoxygenation could come from the BFR. In this situation, the 
hypoxia condition added to the BFR seems to blunt the effect of the BFR. This result is not 
clear because no other study compared the combination of BFR with hypoxia to create a 
HIPC condition.  This was confirmed by the other result where ΔtHb was lower in HIPC than 
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in IPC (P = 0.018) but no difference between the other conditions. For the ΔTSI (%) there was 
no difference between HIPC and the other conditions.  
4.3: Sub-maximal test  
The main result of this study was that the preconditioning had no potentially ergogenic effect 
on the sub-maximal performance. Any of the preconditioning conditions has an impact on 
factors, which could impact the performance on a sub-maximal test. The preconditioning also 
had no beneficial impact on the VO2 kinetics meaning that VO2 kinetics was not enhanced by 
any of the conditions during the preconditioning. There were some impacts of the 
preconditioning on the muscle oxygenation kinetics but not enough to enhance the sub-
maximal performance.  
4.3.1: Physiological responses 	
De Groot Patricia et al (2010) found that cardiac performance was not affected by IPC, 
meaning that the hypothetic beneficial effect on exercise performance occurred independently 
of the cardiac responses. In the current study, HR was lower in IPC than in HPC (trend of P = 
0.062), but IPC was no different than the control condition, which means that IPC had no 
effect on the cardiovascular system. HPC and HIPC also presented no difference with the 
control condition. These results confirm that preconditioning has no effect on the 
cardiovascular work. Regarding the RPE, a study demonstrated no difference in fatigue 
perception between IPC and placebo (Sharma Vikram , 2015). In the current study, there was 
no difference with the RPE of the legs, meaning that the preconditioning had no effect on the 
muscle effort perception. This does not confirm the results of Crisafulli and al (2011), which 
found that there was a beneficial effect of IPC on the perception of fatigue. An interesting 
point is that the RPE of the breathing was higher in the HPC condition than in the HIPC 
condition (P = 0.037). During the HPC the RPE_B was higher, indicating that the 
supplementary work of the respiration during the preconditioning with hypoxia and ischemia 
can decrease the perception of the pulmonary work during the sub-maximal performance, 
which is ultimately beneficial for the performance. This has no direct impact on the sub-
maximal performance but the decrease of the RPE of the pulmonary work could enhance the 
quality of the performance. A previous study showed that IPC maintained a better tissue 
saturation during exercise when compared to the placebo, suggesting that improved oxygen 
delivery to the muscles could be a contributing factor to a better performance (Patterson S D, 
2014.). In the present study, SpO2 was not different in any condition, and thus, there was no 
	 55	
improvement of the oxygen delivery. Bailey T.G et al (2012) speculated that reduced ATP 
consumption or increased efficiency of excitation-contraction coupling during exercise caused 
by preceding IPC could have led to the reduction in muscle lactate production. In the current 
study, however, there were no differences in lactate production between any conditions. This 
may reflect the fact that there was no effect on the ATP consumption by IPC, HPC, or HIPC 
during the sub-maximal performance.  
In this current study, a comparison between the physiological responses during the first trial 
of the sub-maximal test and the four different preconditioning was made. There were no 
impacts of the preconditioning on any of the factors (HR, SpO2, RPE, or lactate) meaning that 
none of the preconditioning conditions had an impact on the sub-maximal performance. 
 
4.3.2: VO2 kinetics 	
The VO2 kinetics can be very important in a sub-maximal performance. The faster the 
response of the VO2 kinetics, the better, partially because of inducing a smaller O2 deficit for 
any given increase in VO2 and intracellular perturbation (Poole David C, 2012). Thus, τVO2 is 
a fundamental parameter of aerobic performance (Whipp BJ, 1970) (Barbosa T.C, 2015), and 
differences in τVO2 (i.e. the speed of the VO2 kinetics) may help explain the broad range of 
physical/athletic capabilities and exercise tolerance across populations (Poole David C, 2012). 
The VO2 measured breath-by-breath in the present study represents the metabolic response. A 
study examining the VO2 kinetics confirms this hypothesis, “the faster O2 kinetics measured 
at the mouth is consistent with the metabolism in the exercise muscle” (Phillips D J, 1997). 
The VO2 measured at the mouth is a representation of what is happening in the muscle, the 
values are not exact but the evolution during the exercise will be similar. Furthermore, 
another study concluded that the kinetics of peripheral muscle oxygenation reflect systemic 
VO2 (Kawaguchi K, 2001). 
The main finding of the current study was that IPC, HPC, and HIPC have no potentially 
ergogenic effect on the VO2 kinetics. The amplitude and the time constant were not enhanced 
with any of the preconditioning conditions. This finding agrees with other studies that found 
no effect of IPC on the VO2 kinetics (Kido Kohei, 2015) (Barbosa T.C, 2015). 
In addition, the present study found that CT1 was slower in HPC condition in comparison 
with the control condition (P = 0.047). This finding means that the HPC condition had a 
negative impact on CT1 of the VO2 kinetics. The time constant was slowed, meaning that the 
VO2 kinetics was also slowed. No other study had found that HPC was detrimental for a sub-
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maximal performance but other studies had found that in acute hypoxia, the VO2 kinetics was 
also slowed (Hughson RL, 1995) (Cleuziou C, 2004). Researchers found that moderate 
hypoxia compared to normoxia induced a similar slowing of the primary component of VO2 
kinetics during moderate and heavy cycling exercises at the same relative intensity (Cleuziou 
C, 2004). This result demonstrates that even after 40 minutes of recovery, the effect of the 
acute hypoxia during PC had an impact on the sub-maximal exercise. The underlying 
mechanisms of this result are not clear but the decrease of the oxygen saturation during the 
preconditioning can impact the reactivity of the VO2 kinetics. Cleuziou C et al (2004) 
suggested that differences in the primary VO2 time constant among our three groups might be 
related to differences in aspects of O2 delivery or oxidative enzyme activity between type I 
and type II fibers. 
The present study concluded no differences in the time delay (TD1) of the VO2 kinetics. 
Poole David C et al (2012) stated that the rapidity of the TD1 (cardio-dynamic responses) is 
attributed to the almost instantaneous cardiac increase which is initiated by vagal withdraw 
and the mechanical pumping action of the contracting muscle. Thus, the current study showed 
that none of the preconditioning had an effect on the immediate responses of the cardio-
dynamic system. This is similar to the findings of Sharma Vikram and al (2015) that 
suggested that the effect of IPC on exercise performance might be achieved by the adaptation 
of local skeletal muscle rather than the systemic cardiovascular system. 
There were no differences in the amplitude (A1) of the VO2 kinetics, meaning that no 
preconditioning had an impact on the amplitude of the VO2 kinetics. Logically, if CT1 or TD1 
were faster or slower together, A1 would be also different. This result shows that the 
preconditioning had no impact on the VO2 kinetics.  
Comparison with the first trial: 
In the current study, an analysis of the effects of the four different preconditioning on the first 
trial of the sub-maximal test was performed. Like the previous results, CT1 was slower on 
HPC in comparison with the control situation (P = 0.047). This confirmed the fact that HPC 
has detrimental impact on the VO2 kinetics. There were no differences between the other 
factors (TD1 and A1). This confirms once again that the preconditioning did not enhance the 
VO2 kinetics.  
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4.3.3: VO2 end trials 
 
In this section, the mean of the last minute of each trials were measured. In the current study, 
expiratory volume (VE), pulmonary oxygen uptake (VO2), pulmonary carbon dioxide uptake 
(VCO2) were also measured. Kido Kohei et al, (2015) found that changes in pulmonary VO2 
throughout the work-to-work test were not significantly different between the control 
condition and the IPC. In this study, VO2, VE and VCO2 were not affected by any conditions, 
for all the parameters there were no differences between the conditions. These findings may 
support the fact that IPC, HPC, and HIPC have no impact on systemic O2 or CO2 responses 
during the sub-maximal test. The respiratory exchange ratio (RER) was also measured, which 
is defined as the ratio of the volume of carbon dioxide given off by the body tissues to the 
volume of oxygen absorbed by them, usually equal to the corresponding volumes given off 
and taken up by the lungs. This RER could indicate a change in the work efficiency, if 
subjects had a RER of 0.7 (more lipids utilization) or of 1.1 (more carbohydrates utilization). 
However in the current study, no change of RER was observed. There were no differences 
between any conditions suggesting that preconditioning did not enhance the work efficiency. 
To complete this result, the energy cost (EC), gross efficiency (GE), and energy expenditure 
(EE) were also calculated. None of the parameters had an impact on the sub-maximal 
performance. There were no differences in any conditions for EC, GE, or EE. This means that 
IPC, HPC, and HIPC had no influence on the respiratory efficiency or the work efficiency.  
Comparison with the first trial: 
In this section only the last minute of the first trial was measured. There were no impacts on 
any factors (VO2, VCO2, RER, EE, EC, and GE). These results indicate that preconditioning 
had no impact on the respiratory efficiency or the work efficiency. Previous studies have 
eluded to potential molecules which may help to understand IPC-induced improvements in 
exercise performance. Those molecules remain relatively unknown, however it is well known 
that nitric oxide (NO) is produced from vascular endothelial cells following an increase in 
shear stress which is induced by the raid increase in blood flow, such as that occurs with 
reperfusion of IPC (Kooijman, 2008). In fact, a recent study determined that IPC increase the 
levels of the blood NO metabolites in human (Rassaf, 2014). Moreover, it has been shown 
that enhanced NO levels reduce the local muscular O2 cost in addition the systemic O2 cost 
during exercise by improving energy efficiency in the mitochondria of the skeletal muscle 
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(Bailey Stephen J, 2010). In the current study the energy cost was not improved, thus the 
implication of NO seems to be inefficient. Another study confirmed that IPC did not affect the 
systemic pulmonary O2 cost during the work-to-work exercise test (Barbosa T.C, 2015). 
4.3.4: Muscle oxygenation kinetics 	
First of all, the main result of this study was that there were no potentially ergogenic effect of 
the preconditioning on the sub-maximal performance. The purpose in this section was to 
determine if there might be some improvements in muscle oxygenation kinetics, which have 
no direct impact on the performance but may be important for the underlying mechanisms of 
preconditioning.  
In this current study, there was a difference between IPC and HIPC with the O2Hb time 
constant (P = 0.039). The time constant of the O2Hb after IPC was slower than after the HIPC. 
The time constant of the O2Hb was enhanced in HIPC when compared with IPC. The 
additional effect of the hypoxia situation (HIPC) had a beneficial effect on the O2Hb. This 
result is quite interesting, given that HPC was not different than the IPC. Thus, the HPC may 
have a beneficial effect only when added to the IPC and blunt the deleterious effect of IPC. 
No other study found the same result, as we believe to be the first to assess HIPC and thus the 
mechanisms remain unclear. The different preconditioning situations had no further effect on 
the muscle oxygenation kinetics. Specifically, there were no effects on the HHb, tHb, or the 
TSI. This result is contradictory to a prior study which found that IPC accelerated muscle 
deoxygenation in moderate-intensity exercise and enhanced severe-intensity exercise during a 
work-to-work cycling exercise, which concluded that IPC could enhance submaximal 
endurance exercise performance (Barbosa T.C, 2015). 
Comparison with the first trial: 
There were some effects with the time constant of O2Hb and HHb of the preconditioning. The 
time constant of O2Hb was slower in IPC than in HIPC, which is the same result as seen 
earlier with the average of the three trials (P = 0.024). The time constant of HHb was faster in 
HPC than in HIPC (P = 0.039). There was a beneficial effect of HPC on the time constant of 
HHb, this can confirm the hypothesis that when hypoxia added to ischemia, there can be 
beneficial on the muscle oxygenation. However, the time constant of HHb in HIPC was 
slower than the other conditions, meaning that when hypoxia is added to ischemia this slowed 
the muscle oxygenation kinetics more than in the other conditions. An explanation can be 
given; part of the NIRS signals parameters indicating muscular O2 extraction; which reflects 
the regional balance between O2 utilization and O2 availability (DeLorey, 1985). Therefore, 
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the HPC induced acceleration of muscle oxygenation kinetics may result from an accelerated 
O2 extraction in skeletal muscle.  
Previous studies have shown that prior muscle contraction can speed up muscle vascular O2 
dynamics during subsequent muscle contractions (Hogan, 2001). In the present study, the 
preconditioning is a prior exercise, as the subjects have been working and contracting the 
muscles before the sub-maximal performance. The 40-minute waiting period between the 
prior exercise and the sub-maximal performance may be too long and therefore annihilate the 
effects. The resting period between the prior exercise and the performance is in studies of six 
minutes (Macdonald Maureen, 1997), thus in this current study the preconditioning has no 
beneficial effect like the prior research indicated. 
4.3.5: Muscle oxygenation end trials  	
After having analyzed the muscle oxygenation kinetics, the purpose of this section is to 
describe the assessment of the mean concentration of muscle oxygenation during the last 
minute at the end of the trials. The previous results show that there were no potentially 
ergogenic effects of the preconditioning on the performance but that there were some impacts 
on the muscle oxygenation.  
The HHb was lower in HPC than in C (P  <0.001), IPC (P = 0.003), and HIPC (P <0.001). 
Previous results shows that the HPC had a deleterious effect on the time constant of the VO2 
kinetics and the current result shows that HPC has also a negative effect on the HHb in 
comparison with the other conditions. The ∆ tHb represents a change of blood volume in the 
muscle (Van Beekvelt M.C, 2001), which tended to be greater with IPC (P = 0.059). This 
means that IPC has a hyperemic effect on the sub-maximal performance and seemed to induce 
a greater muscle perfusion. Salvador et al. (2015) also concluded that after IPC, the tHb 
was higher indicating higher O2 extraction after IPC. This finding is not liked with the VO2 
kinetics because IPC does not enhance the VO2 kinetics but this result is very interesting. In 
the current study, this is the only result that indicated a potentially ergogenic effect of IPC on 
the sub-maximal exercise. The ∆ TSI (%) was higher in HPC than in IPC (P = 0.025), as well 
as higher than HIPC (P = 0.088). Moreover, IPC and HIPC were not different than the control 
condition. The ischemic condition induced a lower ∆ TSI (%). 
4.4: Limitations 
This study has several limitations. The first one was the difficulty of the reproducibility of 
each test for each subject. Subjects were asked to come for each tests at the same hours to 
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avoid differences in the circadian cycle. However, it was impossible to control their activities 
during the day and the hours before the test. Subjects were asked to avoid drinking coffee or 
alcohol the day before the test, which was hard to control. Some of the subjects were students 
and had stress and lack of sleep during the exam period, which was not controlled.  
Secondly, during the familiarization, the critical power was measured with a three-minute all-
out test. During this test, the pacing was not permitted but it was impossible to control if the 
subjects really did not pace. The power during the sub-maximal test was set at 85% of the 
critical power to reach a heavy intensity. However, if some subjects had lower physical 
condition or paced during the three-minute all-out test, the level of power output used during 
the sub-maximal test was not the same. Some of the subjects could be in moderate-heavy 
intensity and other could be in heavy-severe intensity. This difference could affect our results 
and change the performance effects of a preconditioning stimulus.  
Another limitation according to NIRS analyze data, was some missing data after the analysis. 
The reason of this missing data is unknown, as it could be a problem with the data collection 
or with the automation of results in the Excel macro. During the analysis of the muscle 
oxygenation kinetic and the muscle oxygenation end trials, there were some missing data, 
which can reduce the quality of the statistical analysis.  
In the literature on the preconditioning topic, the first limitation is often the lack of bouts 
exercises performed. In the current study, we performed four bouts during the preconditioning 
and three during the sub-maximal exercise.  This adds quality to our study.  
To conclude, this study followed the same protocol as Groot and al (2009) consisting of four 
cycles of 5 min occlusion alternated by 5 min of reperfusion. No study has been performed to 
assess the number of preconditioning cycles and the efficiency (Sharma Vikram , 2015), as 
well as the optimal time lag between the last cuff inflation and the exercise performance 
(Incognito A. V, 2015).  
5: Conclusion and outlook 	
The purpose of the study was to investigate the effects of different preconditioning conditions 
on the VO2 and muscle oxygenation kinetics during a sub-maximal exercise. The main result 
of this study was there were no potentially ergogenic effects of any of the preconditioning on 
the sub-maximal performance. Further, the preconditioning did not enhance the VO2 kinetics 
and the muscle oxygenation kinetics. The physiological responses during the preconditioning 
and the sub-maximal test were also measured, however resulted in no beneficial effects for 
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performance. This study was innovative, as until now, no study has investigated the HPC and 
HIPC on a sub-maximal performance. To conclude, there were two main results of the study, 
which are very interesting and promising for further research. One of the main finding current 
is that with HPC, the VO2  kinetics was slowed during the sub-maximal exercise. This was 
translated with a slowing of the time constant of the VO2  kinetics. Others studies had also 
found this result during acute hypoxia witch the first component of the VO2 kinetics were 
slowed. This means that the preconditioning had an impact on the sub-maximal exercise. The 
second main result is that with IPC there was a higher perfusion during the sub-maximal 
exercise. This was translated by a higher ∆ tHb during the sub-maximal test after IPC. Further 
studies should be performed to investigate the mechanisms provoked by the different 
preconditioning. In this study, there were some effects of the preconditioning on different 
parameters of the sub-maximal exercise but none was enough to have a potentially effect on 
the VO2  and muscle oxygenation kinetics. More studies have to be conducted to understand 
the underlying mechanisms of the preconditioning.  
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